Supavit Chesdachai
Overview
Explore the profile of Supavit Chesdachai including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
391
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
McHugh J, Gomez E, Abu-Saleh O, Corsini Campioli C, Chesdachai S, Nazli S, et al.
Mayo Clin Proc
. 2025 Mar;
100(3):534-539.
PMID: 40044363
We report a case of mpox in a patient with a signal transducer and activator of transcription 1 gain-of-function mutation. Despite initial improvement with intravenous immune globulin and tecovirimat, severe...
2.
Mendoza M, Fugate J, Kukla A, Razonable R, Chesdachai S
N Engl J Med
. 2025 Mar;
392(10):1018-1024.
PMID: 40043240
No abstract available.
3.
Chesdachai S, Baddour L, Tabaja H, Madhavan M, Anavekar N, Zwischenberger B, et al.
Clin Infect Dis
. 2025 Feb;
80(1):1-3.
PMID: 39908173
Cardiac implantable electronic device infections (CIEDIs) present substantial challenges for infectious diseases specialists, encompassing diagnosis, management, and complex decision-making involving patients, families, and multidisciplinary teams. This review, guided by a...
4.
Chesdachai S, Baddour L, Tabaja H, Madhavan M, Anavekar N, Zwischenberger B, et al.
Clin Infect Dis
. 2025 Feb;
80(1):e1-e15.
PMID: 39908172
Cardiac implantable electronic device infections (CIEDIs) present substantial challenges for infectious diseases specialists, encompassing diagnosis, management, and complex decision making involving patients, families, and multidisciplinary teams. This review, guided by...
5.
Comprehensive Assessment of the Risk of Symptomatic Embolism in Patients With Infective Endocarditis
Santos-Patarroyo S, Quintero-Martinez J, Lahr B, Chesdachai S, DeSimone D, Villarraga H, et al.
J Am Heart Assoc
. 2025 Jan;
14(3):e036648.
PMID: 39846279
Background: Echocardiographic evaluation of vegetations is crucial in infective endocarditis (IE). Although several studies have noted a link between larger vegetations and an increased risk of embolization, a more comprehensive...
6.
Chesdachai S, Baddour L, DeSimone D
Clin Infect Dis
. 2024 Dec;
PMID: 39718372
A distinction between infections of left ventricular assist devices (LVADs) and cardiac implantable electronic devices (CIEDs) is warranted as they differ markedly in incidence, microbiologic profiles, clinical presentations, and extraction...
7.
Chiu C, Razonable R, Yao J, Watt K, Chesdachai S
Hepatol Commun
. 2024 Dec;
9(1).
PMID: 39670867
Background: Diagnostic uncertainty caused by the low positive predictive value of HEV-specific IgM antibody (Ab) testing in a low-prevalence setting. We investigated the utility of a two-step HEV IgM Ab...
8.
Chesdachai S, DeSimone D, Baddour L
J Am Coll Cardiol
. 2024 Nov;
85(4):319-321.
PMID: 39580720
No abstract available.
9.
Khodadadi R, McHugh J, Chesdachai S, Wengenack N, Bosch W, Seville M, et al.
J Bone Jt Infect
. 2024 Nov;
9(5):207-212.
PMID: 39539732
: is an uncommon pathogen that has been reported to infect musculoskeletal structures. However, studies are largely limited to case reports, and little is known regarding management and outcomes of...
10.
Gow-Lee V, Abu Saleh O, Harris C, Gile J, Akhiyat N, Chesdachai S
Pathogens
. 2024 Oct;
13(10).
PMID: 39452757
Background: Isavuconazole (ISA) has a favorable side effect profile that makes it attractive for treatment of invasive fungal infections (IFI). It carries FDA approval for invasive aspergillosis and mucormycosis, but...